Medidata Solutions Coverage Initiated at Morgan Stanley (MDSO)
Equities researchers at Morgan Stanley initiated coverage on shares of Medidata Solutions (NASDAQ:MDSO) in a research report issued on Thursday. The firm set an “overweight” rating and a $56.00 price target on the stock. Morgan Stanley’s price target points to a potential upside of 19.12% from the company’s current price.
In other Medidata Solutions news, EVP Bryan Charles Spielman sold 20,000 shares of the stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $47.73, for a total value of $954,600.00. The sale was disclosed in a filing with the SEC, which is available at this link.
Other equities research analysts have also recently issued reports about the stock. Analysts at Stifel Nicolaus raised their price target on shares of Medidata Solutions from $47.00 to $55.00 in a research note on Thursday, July 31st. Separately, analysts at Topeka Capital Markets reiterated a “buy” rating on shares of Medidata Solutions in a research note on Wednesday, July 30th. They now have a $50.00 price target on the stock, up previously from $49.00. Finally, analysts at Jefferies Group raised their price target on shares of Medidata Solutions from $50.00 to $53.00 in a research note on Wednesday, July 30th. They now have a “buy” rating on the stock. Two analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $57.27.
Shares of Medidata Solutions (NASDAQ:MDSO) opened at 47.00 on Thursday. Medidata Solutions has a 52-week low of $32.10 and a 52-week high of $68.21. The stock’s 50-day moving average is $44.0 and its 200-day moving average is $46.65. The company has a market cap of $2.478 billion and a price-to-earnings ratio of 388.52.
Medidata Solutions (NASDAQ:MDSO) last released its earnings data on Tuesday, July 29th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by $0.01. The company had revenue of $83.20 million for the quarter, compared to the consensus estimate of $81.90 million. During the same quarter in the previous year, the company posted $0.36 earnings per share. The company’s revenue for the quarter was up 22.2% on a year-over-year basis. Analysts expect that Medidata Solutions will post $0.76 EPS for the current fiscal year.
Medidata Solutions, Inc (NASDAQ:MDSO) is a global provider of software-as-a-service (SaaS), clinical technology solutions.
Receive News & Ratings for Medidata Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.